Analysis of the concentrations of proteins associated with bone metabolism revealed no statistically significant differences in the level of osteoprotegerin, osteopontin, or MPG between the control group and patients with chronic kidney disease (all stages). This evidence concerns the gene TNFRSF11B and chronic kidney disease.